雨渐耳符咒有什么用

百度 近十多年来《经济研究》适应社会主义市场经济发展的要求和中国经济学理论发展的新形势，及时更新研究主题，密切关注现代经济学新的研究方法，积极加强对重大现实问题的理论研究，并在国内经济理论期刊中率先实行专家匿名审稿制度，努力不断提高期刊质量，在国内外产生了重要的影响，受到了广泛的好评。

BEIJING, June 30 (Xinhua) -- The National Natural Science Foundation of China (NSFC) on Monday launched the Private Enterprise Innovation and Development Joint Fund, which aims to empower private companies to officially participate in national basic research.

Under the fund's framework, private enterprises will identify critical research challenges based on their specific innovation needs and the joint fund will sponsor top researchers nationwide to tackle these defined problems.

NSFC Director Dou Xiankang stated that the fund aims to leverage the NSFC's guiding role, encouraging innovation-driven private enterprises to boost their investment in foundational research.

The initiative seeks to concentrate China's leading scientific resources on core scientific issues within key technological fields. It will focus on basic and applied basic research tightly aligned with urgent national economic and social development needs. This approach is designed to foster deep integration between technological and industrial innovation, energize private sector innovation, and inject fresh momentum into China's innovation-driven development strategy.

The inaugural partners in the fund are four major pharmaceutical firms: Hengrui Pharmaceuticals, Mindray Bio-Medical, Singclean Medical, and Qilu Pharmaceutical.

The NSFC intends to maximize the fund's steering function, broadly attracting high-caliber scientific talent across society to advance basic research in the medical field and collectively push the boundaries of independent innovation.